Search Results
Post-Issuance Tax Compliance and Continuing Disclosure Responsibilities for Issuers and Borrowers of Tax-Exempt Bonds (Second Edition)
by Edwin Oswald and Aviva M. Roth | February.22.2022
Orrick is pleased to announce the second edition of our publication of "Post-Issuance Tax Compliance and Continuing Disclosure Responsibilities for Issuers and Borrowers of Tax-Exempt Bonds". It is intended to assist treasurers, finance directors, comptrollers, controllers and other responsible officials of state and local government issuers of tax-exempt bonds and representatives of private, nongovernmental conduit borrowers (such as nonprofit institutions providing health care and higher education) that are allowed to borrow at tax-exempt rates from issuers.
If you have any questions or if ...
Tax-Exempt Bond Financing for Middle-Income Housing
January.09.2024
This booklet introduces the ways tax-exempt bonds can help produce rent- and income-restricted middle-income or “workforce” housing.
Practices
Financial Services Investigations & Enforcement
Orrick helps financial services and fintech companies navigate government investigations and enforcement actions from the CFPB, FTC, FDIC, OCC, DOJ, ...
Financial Services Investigations & Enforcement
Orrick helps financial services and fintech companies navigate government investigations and enforcement actions from the CFPB, FTC, FDIC, OCC, DOJ, HUD, AGs, Congress, and CFTC.
Managing Fraud Risk in Consumer Wires
by Edward Somers, Elizabeth McGinn and Hayden Irwin | March.06.2025
In 2025, a federal district court has broadened a consumer protection law to cover wire transfers, impacting financial services.
Legislation Relating to Public Finance Enacted by the 86th Texas Legislature (Regular Session)
by Jerry V. Kyle Jr. and Taylor Raymond | June.25.2019
This document briefly summarizes a select list of legislation relating to public finance enacted by the 86th Legislature (Regular Session) that became law.
IJInvestor Awards: Orrick Named Legal Adviser of the Year, Europe 2023
December.01.2023
Orrick has been named “Legal Adviser of the Year – Europe” at the 2023 IJInvestor Awards, which recognize best-in-class transactions and organizations across the international energy and infrastructure industry.
Orrick Continues East Coast Growth with Executive Comp & Benefits Partner Laura Bagarella in New York
April.01.2024
Laura Bagarella joins Orrick’s Compensation & Benefits group as a partner.
Practices
Assessment and Special Tax Bonds and Land Secured Financing
Infrastructure finance has always been, and continues to be, at the core of Orrick's public finance practice.
Assessment and Special Tax Bonds and Land Secured Financing
Infrastructure finance has always been, and continues to be, at the core of Orrick's public finance practice.
Higher Education, Exempt Organization & Governmental Financings - Tax Presentation
by Larry Sobel and Charles C. Cardall | November.07.2016
Topics covered:
Qualified Equity - Allocation & Accounting Rules for Private Business Use
Refunding Into Flexibility - Anticipatory Remedial Action In Connection With A Refunding
Maximizing The Insubstantial - Multipurpose Elections &The $15 Million Limitation
The Changing Landscape Of Private Service Contracts: Revenue Procedure 2016-44
Private Business Use - Research Contracts
Private Business Use - Material Transfer Agreements
Private Business Use - Incidental Use Exception & Examples & Short Term Use Exception
Private ...
Practices
FDA & Healthcare Regulatory
A team helping life sciences and healthtech companies navigate the complex regulatory landscape related to the U.S. Food and Drug Administration.
FDA & Healthcare Regulatory
A team helping life sciences and healthtech companies navigate the complex regulatory landscape related to the U.S. Food and Drug Administration.
FDA Issues Draft Guidance on AI-Enabled Medical Devices
by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph | January.07.2025
The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices.